 Eric Pietras
Concepts (310)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 37 | 2025 | 406 | 10.580 |
Why?
| | Hematopoiesis | 15 | 2025 | 192 | 3.450 |
Why?
| | Bone Marrow | 10 | 2024 | 286 | 1.900 |
Why?
| | Stem Cell Niche | 8 | 2025 | 54 | 1.660 |
Why?
| | Dioxygenases | 3 | 2022 | 26 | 1.600 |
Why?
| | Neoplastic Stem Cells | 5 | 2024 | 399 | 1.380 |
Why?
| | Inflammation | 13 | 2025 | 2837 | 1.350 |
Why?
| | Myelodysplastic Syndromes | 4 | 2024 | 135 | 1.260 |
Why?
| | Stress, Physiological | 3 | 2021 | 443 | 1.150 |
Why?
| | Proto-Oncogene Proteins | 5 | 2022 | 648 | 1.120 |
Why?
| | Mice | 44 | 2025 | 17787 | 1.110 |
Why?
| | Interferon Type I | 5 | 2014 | 140 | 1.030 |
Why?
| | Cell Proliferation | 9 | 2021 | 2475 | 1.020 |
Why?
| | Leukemia | 4 | 2022 | 240 | 1.000 |
Why?
| | Cell Cycle | 5 | 2021 | 601 | 0.960 |
Why?
| | Trans-Activators | 3 | 2022 | 398 | 0.910 |
Why?
| | Animals | 56 | 2025 | 36940 | 0.900 |
Why?
| | Cell Differentiation | 12 | 2025 | 1991 | 0.870 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2023 | 23 | 0.810 |
Why?
| | Leukemia, Myeloid | 1 | 2022 | 45 | 0.780 |
Why?
| | Signal Transduction | 17 | 2025 | 5079 | 0.760 |
Why?
| | Multipotent Stem Cells | 3 | 2021 | 20 | 0.750 |
Why?
| | Cell Lineage | 4 | 2021 | 350 | 0.730 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2024 | 630 | 0.690 |
Why?
| | Oxidative Phosphorylation | 2 | 2025 | 193 | 0.690 |
Why?
| | Epigenesis, Genetic | 3 | 2024 | 660 | 0.680 |
Why?
| | Interleukin-1 | 4 | 2023 | 965 | 0.670 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2022 | 1242 | 0.670 |
Why?
| | Endothelial Protein C Receptor | 1 | 2019 | 5 | 0.660 |
Why?
| | Antigens, CD34 | 1 | 2019 | 88 | 0.640 |
Why?
| | Hematologic Diseases | 2 | 2023 | 62 | 0.640 |
Why?
| | Flow Cytometry | 5 | 2021 | 1178 | 0.640 |
Why?
| | Mice, Inbred C57BL | 18 | 2025 | 5757 | 0.620 |
Why?
| | Mutation | 11 | 2025 | 3958 | 0.600 |
Why?
| | Stem Cell Factor | 1 | 2018 | 15 | 0.590 |
Why?
| | DNA-Binding Proteins | 4 | 2022 | 1502 | 0.570 |
Why?
| | Macrophages | 3 | 2024 | 1547 | 0.560 |
Why?
| | Arthritis, Experimental | 1 | 2019 | 147 | 0.550 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 697 | 0.540 |
Why?
| | Health | 1 | 2017 | 84 | 0.530 |
Why?
| | Disease | 1 | 2017 | 98 | 0.520 |
Why?
| | Immunity, Innate | 6 | 2023 | 828 | 0.470 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 460 | 0.460 |
Why?
| | Virus Diseases | 2 | 2008 | 212 | 0.450 |
Why?
| | Monocytes | 2 | 2022 | 563 | 0.440 |
Why?
| | Regeneration | 3 | 2025 | 197 | 0.440 |
Why?
| | Cytokines | 7 | 2020 | 2085 | 0.430 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2021 | 622 | 0.430 |
Why?
| | HMGA2 Protein | 1 | 2013 | 9 | 0.420 |
Why?
| | Myeloid Cells | 3 | 2025 | 148 | 0.400 |
Why?
| | Inflammation Mediators | 2 | 2020 | 513 | 0.390 |
Why?
| | Proto-Oncogene Proteins c-ets | 2 | 2022 | 56 | 0.360 |
Why?
| | Repressor Proteins | 3 | 2025 | 427 | 0.350 |
Why?
| | Receptors, CCR2 | 1 | 2011 | 40 | 0.350 |
Why?
| | Receptors, Interferon | 1 | 2011 | 52 | 0.350 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2011 | 99 | 0.350 |
Why?
| | Aging | 7 | 2025 | 1864 | 0.350 |
Why?
| | Francisella tularensis | 1 | 2011 | 32 | 0.340 |
Why?
| | Germ-Line Mutation | 2 | 2022 | 172 | 0.340 |
Why?
| | Phosphoproteins | 3 | 2020 | 338 | 0.340 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4295 | 0.330 |
Why?
| | DNA | 1 | 2017 | 1459 | 0.330 |
Why?
| | Humans | 41 | 2025 | 137585 | 0.330 |
Why?
| | Arthritis, Rheumatoid | 1 | 2019 | 1167 | 0.330 |
Why?
| | Gene Expression | 5 | 2021 | 1502 | 0.330 |
Why?
| | Neutrophils | 6 | 2025 | 1238 | 0.320 |
Why?
| | RNA Splicing Factors | 2 | 2020 | 53 | 0.320 |
Why?
| | Host-Pathogen Interactions | 2 | 2021 | 364 | 0.320 |
Why?
| | Neoplasms | 3 | 2022 | 2671 | 0.310 |
Why?
| | TNF Receptor-Associated Death Domain Protein | 1 | 2008 | 2 | 0.300 |
Why?
| | Mitochondria | 5 | 2025 | 948 | 0.300 |
Why?
| | Cell Cycle Proteins | 2 | 2011 | 617 | 0.290 |
Why?
| | Viruses | 2 | 2008 | 113 | 0.290 |
Why?
| | Stem Cells | 3 | 2022 | 594 | 0.280 |
Why?
| | Mice, Transgenic | 5 | 2023 | 2167 | 0.280 |
Why?
| | Homeostasis | 2 | 2021 | 621 | 0.270 |
Why?
| | Immunity | 1 | 2008 | 143 | 0.270 |
Why?
| | Mitochondrial Proteins | 2 | 2008 | 257 | 0.260 |
Why?
| | MicroRNAs | 1 | 2013 | 692 | 0.260 |
Why?
| | Reactive Oxygen Species | 2 | 2020 | 622 | 0.260 |
Why?
| | Interleukin-1beta | 3 | 2021 | 372 | 0.250 |
Why?
| | Diet, Western | 2 | 2023 | 81 | 0.240 |
Why?
| | Receptors, Colony-Stimulating Factor | 1 | 2025 | 7 | 0.240 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2025 | 27 | 0.240 |
Why?
| | Glycolysis | 2 | 2024 | 321 | 0.230 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 32 | 0.230 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2025 | 72 | 0.230 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2025 | 25 | 0.230 |
Why?
| | Semaphorins | 1 | 2025 | 32 | 0.220 |
Why?
| | Bacterial Infections | 1 | 2006 | 250 | 0.210 |
Why?
| | Splicing Factor U2AF | 2 | 2023 | 16 | 0.210 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2022 | 164 | 0.200 |
Why?
| | Interferon Regulatory Factors | 2 | 2020 | 39 | 0.200 |
Why?
| | B-Lymphocytes | 3 | 2022 | 847 | 0.200 |
Why?
| | Transcriptional Activation | 1 | 2025 | 378 | 0.200 |
Why?
| | fas Receptor | 4 | 2008 | 95 | 0.190 |
Why?
| | Liver | 2 | 2024 | 1943 | 0.190 |
Why?
| | Apoptosis | 6 | 2025 | 2553 | 0.190 |
Why?
| | Spliceosomes | 2 | 2020 | 48 | 0.190 |
Why?
| | Leukocytes | 1 | 2024 | 311 | 0.190 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 91 | 0.190 |
Why?
| | Cholinergic Agents | 1 | 2022 | 18 | 0.190 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2024 | 242 | 0.190 |
Why?
| | Up-Regulation | 3 | 2021 | 843 | 0.190 |
Why?
| | Autoimmunity | 2 | 2025 | 908 | 0.190 |
Why?
| | Mice, Knockout | 6 | 2025 | 3015 | 0.180 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2021 | 37 | 0.180 |
Why?
| | Receptors, Notch | 2 | 2020 | 88 | 0.180 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2022 | 327 | 0.180 |
Why?
| | Myelopoiesis | 2 | 2018 | 8 | 0.170 |
Why?
| | Clone Cells | 1 | 2021 | 265 | 0.170 |
Why?
| | Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 15 | 0.170 |
Why?
| | Carcinogenesis | 1 | 2022 | 217 | 0.170 |
Why?
| | Bone Marrow Diseases | 1 | 2020 | 19 | 0.170 |
Why?
| | DNA Damage | 2 | 2021 | 420 | 0.170 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 114 | 0.170 |
Why?
| | Drug Therapy | 1 | 2020 | 85 | 0.170 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 66 | 0.160 |
Why?
| | Cellular Reprogramming | 3 | 2017 | 99 | 0.160 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 151 | 0.160 |
Why?
| | Staphylococcus aureus | 3 | 2010 | 450 | 0.160 |
Why?
| | Bacteria | 1 | 2006 | 858 | 0.150 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2019 | 22 | 0.150 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 289 | 0.150 |
Why?
| | Histone Deacetylases | 1 | 2020 | 215 | 0.150 |
Why?
| | Darkness | 1 | 2018 | 28 | 0.150 |
Why?
| | Thrombocytopenia | 1 | 2020 | 200 | 0.150 |
Why?
| | Interferon Inducers | 1 | 2018 | 8 | 0.140 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 192 | 0.140 |
Why?
| | Staphylococcal Skin Infections | 2 | 2010 | 35 | 0.140 |
Why?
| | Poly I-C | 1 | 2018 | 63 | 0.140 |
Why?
| | Cells, Cultured | 5 | 2021 | 4193 | 0.140 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 434 | 0.140 |
Why?
| | Models, Biological | 3 | 2015 | 1783 | 0.140 |
Why?
| | Granulocyte-Macrophage Progenitor Cells | 1 | 2017 | 6 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 496 | 0.140 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2019 | 366 | 0.130 |
Why?
| | Cell Self Renewal | 1 | 2017 | 56 | 0.130 |
Why?
| | Heart Diseases | 1 | 2020 | 346 | 0.130 |
Why?
| | Intervertebral Disc | 1 | 2017 | 39 | 0.130 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2020 | 801 | 0.130 |
Why?
| | Neutrophil Infiltration | 2 | 2007 | 107 | 0.130 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2006 | 5 | 0.130 |
Why?
| | Antineoplastic Agents | 4 | 2020 | 2129 | 0.120 |
Why?
| | Blood Platelets | 1 | 2019 | 408 | 0.120 |
Why?
| | Lymphoid Progenitor Cells | 1 | 2015 | 11 | 0.120 |
Why?
| | Thrombosis | 1 | 2019 | 371 | 0.120 |
Why?
| | Myeloid Progenitor Cells | 1 | 2015 | 17 | 0.120 |
Why?
| | RNA Splicing | 3 | 2023 | 269 | 0.120 |
Why?
| | Bone Marrow Transplantation | 1 | 2016 | 286 | 0.110 |
Why?
| | Cell Division | 1 | 2016 | 794 | 0.110 |
Why?
| | Mice, Congenic | 1 | 2014 | 22 | 0.110 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2014 | 15 | 0.110 |
Why?
| | Primary Myelofibrosis | 1 | 2013 | 10 | 0.100 |
Why?
| | Cell Cycle Checkpoints | 1 | 2014 | 98 | 0.100 |
Why?
| | Myeloproliferative Disorders | 1 | 2013 | 27 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2006 | 430 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2018 | 785 | 0.100 |
Why?
| | DNA Replication | 1 | 2014 | 238 | 0.100 |
Why?
| | Primates | 2 | 2024 | 126 | 0.100 |
Why?
| | Cellular Senescence | 1 | 2014 | 189 | 0.100 |
Why?
| | TNF Receptor-Associated Factor 3 | 3 | 2007 | 5 | 0.100 |
Why?
| | Cell Survival | 2 | 2014 | 1120 | 0.100 |
Why?
| | Transcription Factors | 2 | 2018 | 1719 | 0.090 |
Why?
| | Embryo, Mammalian | 1 | 2011 | 232 | 0.090 |
Why?
| | Tularemia | 1 | 2011 | 29 | 0.090 |
Why?
| | Chemokine CCL2 | 1 | 2011 | 115 | 0.090 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 122 | 0.090 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2025 | 385 | 0.080 |
Why?
| | Megakaryocytes | 2 | 2020 | 34 | 0.080 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 528 | 0.080 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 422 | 0.080 |
Why?
| | Gene Deletion | 1 | 2011 | 391 | 0.080 |
Why?
| | Interleukin-17 | 1 | 2010 | 119 | 0.080 |
Why?
| | Spleen | 1 | 2011 | 514 | 0.080 |
Why?
| | Receptors, Interleukin-1 | 2 | 2007 | 216 | 0.070 |
Why?
| | Cell Line | 5 | 2021 | 2847 | 0.070 |
Why?
| | Male | 10 | 2025 | 67762 | 0.070 |
Why?
| | RNA Viruses | 1 | 2008 | 43 | 0.070 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2007 | 16 | 0.070 |
Why?
| | Dinucleoside Phosphates | 1 | 2007 | 27 | 0.070 |
Why?
| | Skin | 2 | 2010 | 752 | 0.070 |
Why?
| | Endopeptidases | 1 | 2007 | 90 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 167 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2011 | 778 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2025 | 900 | 0.070 |
Why?
| | Caspases | 2 | 2005 | 247 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 4149 | 0.060 |
Why?
| | Antibody Formation | 1 | 2007 | 298 | 0.060 |
Why?
| | RNA, Double-Stranded | 1 | 2006 | 57 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2019 | 886 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 57 | 0.060 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 500 | 0.060 |
Why?
| | Interleukin-15 | 1 | 2025 | 98 | 0.060 |
Why?
| | Toll-Like Receptors | 1 | 2006 | 185 | 0.060 |
Why?
| | Receptor, Notch1 | 1 | 2025 | 64 | 0.060 |
Why?
| | Listeria monocytogenes | 1 | 2006 | 126 | 0.060 |
Why?
| | Organophosphorus Compounds | 1 | 2025 | 78 | 0.060 |
Why?
| | Interleukin-2 | 1 | 2025 | 455 | 0.050 |
Why?
| | Female | 7 | 2023 | 73304 | 0.050 |
Why?
| | Bone Marrow Cells | 3 | 2011 | 316 | 0.050 |
Why?
| | Staphylococcal Infections | 1 | 2007 | 400 | 0.050 |
Why?
| | Chemotaxis | 1 | 2023 | 131 | 0.050 |
Why?
| | Thrombopoiesis | 1 | 2022 | 8 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2004 | 510 | 0.050 |
Why?
| | Immunophenotyping | 1 | 2024 | 318 | 0.050 |
Why?
| | RNA, Viral | 1 | 2006 | 656 | 0.050 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2008 | 188 | 0.050 |
Why?
| | Macaca mulatta | 1 | 2022 | 166 | 0.050 |
Why?
| | Germ Cells | 1 | 2022 | 64 | 0.050 |
Why?
| | Time-Lapse Imaging | 1 | 2021 | 21 | 0.050 |
Why?
| | Mice, SCID | 1 | 2022 | 367 | 0.050 |
Why?
| | Leukemia, Myelomonocytic, Acute | 1 | 2021 | 7 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1774 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 56 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 601 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2021 | 402 | 0.040 |
Why?
| | DNA Methylation | 1 | 2025 | 643 | 0.040 |
Why?
| | Cell Movement | 1 | 2004 | 967 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 976 | 0.040 |
Why?
| | Adoptive Transfer | 1 | 2020 | 219 | 0.040 |
Why?
| | Fetus | 1 | 2024 | 806 | 0.040 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2019 | 26 | 0.040 |
Why?
| | K562 Cells | 1 | 2019 | 89 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 50 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 93 | 0.040 |
Why?
| | Protein Transport | 1 | 2020 | 445 | 0.040 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 95 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2019 | 118 | 0.040 |
Why?
| | Antigens, CD | 1 | 2021 | 521 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 730 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2018 | 26 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 88 | 0.040 |
Why?
| | Fluorouracil | 1 | 2019 | 208 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 5742 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 283 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2019 | 404 | 0.030 |
Why?
| | NF-kappa B | 3 | 2007 | 691 | 0.030 |
Why?
| | Granulocytes | 1 | 2017 | 80 | 0.030 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 298 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2017 | 56 | 0.030 |
Why?
| | T-Lymphocytes | 2 | 2018 | 1996 | 0.030 |
Why?
| | Interferon-alpha | 2 | 2007 | 198 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 840 | 0.030 |
Why?
| | Osteogenesis | 1 | 2017 | 188 | 0.030 |
Why?
| | Caspase 8 | 2 | 2005 | 48 | 0.030 |
Why?
| | beta Catenin | 1 | 2017 | 253 | 0.030 |
Why?
| | Minichromosome Maintenance Proteins | 1 | 2014 | 5 | 0.030 |
Why?
| | Fas Ligand Protein | 2 | 2005 | 60 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 657 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2014 | 88 | 0.030 |
Why?
| | Thrombopoietin | 1 | 2013 | 5 | 0.030 |
Why?
| | Chemokine CCL3 | 1 | 2013 | 16 | 0.030 |
Why?
| | Cell Transdifferentiation | 1 | 2013 | 31 | 0.030 |
Why?
| | Protein Binding | 1 | 2018 | 2224 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2426 | 0.020 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2011 | 40 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2011 | 77 | 0.020 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2011 | 69 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2013 | 480 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3196 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6763 | 0.020 |
Why?
| | Histones | 1 | 2014 | 636 | 0.020 |
Why?
| | Hematologic Neoplasms | 1 | 2011 | 156 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2008 | 134 | 0.020 |
Why?
| | Interleukins | 1 | 2010 | 250 | 0.020 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2007 | 21 | 0.020 |
Why?
| | Toll-Like Receptor 3 | 1 | 2007 | 28 | 0.020 |
Why?
| | Risk Factors | 1 | 2022 | 10388 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 233 | 0.020 |
Why?
| | Ubiquitin | 1 | 2007 | 70 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2007 | 58 | 0.020 |
Why?
| | Neutrophil Activation | 1 | 2007 | 80 | 0.020 |
Why?
| | Ubiquitination | 1 | 2007 | 102 | 0.020 |
Why?
| | STAT1 Transcription Factor | 1 | 2007 | 72 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2007 | 225 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2007 | 158 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 494 | 0.020 |
Why?
| | Sendai virus | 1 | 2006 | 5 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2010 | 789 | 0.020 |
Why?
| | DNA Primers | 1 | 2007 | 515 | 0.020 |
Why?
| | Intracellular Fluid | 1 | 2006 | 27 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 455 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5472 | 0.010 |
Why?
| | Death Domain Receptor Signaling Adaptor Proteins | 1 | 2005 | 2 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 622 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 861 | 0.010 |
Why?
| | Dactinomycin | 1 | 2005 | 28 | 0.010 |
Why?
| | Cycloheximide | 1 | 2005 | 55 | 0.010 |
Why?
| | Toll-Like Receptor 2 | 1 | 2006 | 115 | 0.010 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2005 | 25 | 0.010 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2005 | 49 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2607 | 0.010 |
Why?
| | Chemokines | 1 | 2006 | 228 | 0.010 |
Why?
| | Caspase Inhibitors | 1 | 2005 | 81 | 0.010 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2004 | 29 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2005 | 269 | 0.010 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 52 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2007 | 483 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2139 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2005 | 810 | 0.010 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2003 | 194 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2900 | 0.010 |
Why?
| | Phosphorylation | 1 | 2007 | 1759 | 0.010 |
Why?
| | Oligopeptides | 1 | 2005 | 271 | 0.010 |
Why?
| | MAP Kinase Signaling System | 1 | 2004 | 320 | 0.010 |
Why?
| | Alleles | 1 | 2005 | 891 | 0.010 |
Why?
| | Child | 1 | 2020 | 21935 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2005 | 3412 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 33479 | 0.010 |
Why?
|
|
Pietras's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|